Company / Current Liabilities
Entera Bio Ltd. Current Liabilities History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.2M
FY2025
5-year range
$1.1M / $3.2M
FY2021-FY2025
Trend
+87.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $1M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 3-year CAGR of +18.0%.
Increased from $1M to $2M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +18.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +18.0%, indicating consistent growth.
- In FY2025, current liabilities increased 87.3% year-over-year.
- Peak current liabilities was recorded in FY2021.
- Lowest current liabilities in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2M | +87.3% |
| FY2024 | $1.2M | +7.8% |
| FY2023 | $1.1M | -18.6% |
| FY2022 | $1.3M | -57.6% |
| FY2021 | $3.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026